Novel role of the lncRNA EPR as oncosuppressor in intestinal cancer.
Naomi Shim, Maira Rossi, Monica M Nicolau…·Luca Caputo
The paper identifies EPR as an oncosuppressor in intestinal cancer, showing its role in goblet cell development and its potential as a prognostic marker and therapeutic target.